Home
About Journal
For Author
Periodical
Contact Us
中文
Introduction
Editorial Board
Aims and Scope
Open Access Statement
Publication Ethics Statement
Medical Ethics Requirements
Advertisement and Marketing Policy
Submission Guidelines
Author Standards
The Payment
The Archiving Policy
Errata
The analysis of efficacy and safety of tislelizumab versus pembrolizumab with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma
Yufei ZHU,Zhihao HUANG,Yichen CAI,Yunyun ZENG,Huiyi HUANG,Jun SUN,Shan SU
The Journal of Practical Medicine . 2025, (
7
): 1024 -1029 . DOI: 10.3969/j.issn.1006-5725.2025.07.014
